Literature DB >> 23360205

Distension-evoked motility analysis in human esophagus.

D Liao1, G E Villadsen, H Gregersen.   

Abstract

BACKGROUND: The major function of the esophagus is to transport food from the mouth to the stomach by peristaltic muscle action. However, only few techniques exist for detailed evaluation of motor activity of the esophagus in vivo. The aim of this study is to use distension combined with manometry and impedance planimetry [pressure-cross-sectional area (P-CSA) recordings] to assess esophageal peristaltic motor function in terms of the mechanical energy output, and to examine the change in the motor activity of the esophagus in response to butylscopolamine, an anticholinergic drug known to impair the smooth muscle contraction in the gastrointestinal tract.
METHODS: The probe with CSA measurements was positioned 7 cm above the lower esophageal sphincter in 16 healthy volunteers before and during butylscopolamine administration. Distension-evoked esophageal peristalsis was analyzed using P-CSA data during distension up to pressures of 5 kPa. The P-CSA, work output (area of the tension-CSA curves), and propulsive tension were analyzed. KEY
RESULTS: The wave-like peristalsis resulted in P-CSA loops consisting of relaxation and contraction phases. The work increased with the distension pressure (from 1311 ± 198 to 16 330 ± 1845 μJ before butylscopolamine vs from 2615 ± 756 to 11 404 ± 1335 μJ during butylscopolamine administration), and propulsive tension increased from 18.7 ± 1.9 to 88.5 ± 5.5 N m(-1) before the drug and from 23.1 ± 3.9 to 79.5 ± 3.3 N m(-1) during butylscopolamine administration). Significantly, lower values were found during butylscopolamine administration compared with the distension before using the drug (P < 0.01). CONCLUSIONS & INFERENCES: Esophageal muscle properties during peristalsis can be assessed in vivo in terms of mechanical energy output parameters. Butylscopolamine impaired muscle contraction which could be detected as altered contraction parameters. The analysis can be further used as an adjunct tool of the combined manometry and impedance planimetry recordings to derive advanced esophageal motor function parameters for studying the physiological and pathophysiological mechanical consequences of esophageal contractions.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360205     DOI: 10.1111/nmo.12081

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  5 in total

1.  Quantitative differences between primary and secondary peristaltic contractions of the esophagus.

Authors:  Donghua Liao; Anne Lund Krarup; Flemming Holbæk Lundager; Asbjørn Mohr Drewes; Hans Gregersen
Journal:  Dig Dis Sci       Date:  2014-02-28       Impact factor: 3.199

2.  Utilizing functional lumen imaging probe topography to evaluate esophageal contractility during volumetric distention: a pilot study.

Authors:  D A Carlson; Z Lin; M C Rogers; C Y Lin; P J Kahrilas; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2015-04-20       Impact factor: 3.598

3.  Assessment of esophageal body peristaltic work using functional lumen imaging probe panometry.

Authors:  Shashank Acharya; Sourav Halder; Dustin A Carlson; Wenjun Kou; Peter J Kahrilas; John E Pandolfino; Neelesh A Patankar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-11-11       Impact factor: 4.052

Review 4.  What Is the Future of Impedance Planimetry in Gastroenterology?

Authors:  Hans Gregersen; Kar Man Lo
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

5.  Axial Movements and Length Changes of the Human Lower Esophageal Sphincter During Respiration and Distension-induced Secondary Peristalsis Using Functional Luminal Imaging Probe.

Authors:  Donghua Liao; Christian Lottrup; Lotte Fynne; Barry P McMahon; Klaus Krogh; Asbjørn M Drewes; Jingbo Zhao; Hans Gregersen
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.